David T. MacLaughlin

Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells

Richard L. Cate, Robert J. Mattaliano, Catherine Hession et al. · Cell · 1986 · 1K citations

Life Sciences, Genetics, Molecular Genetics +4

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

Paul P. Szotek, Rafael Pieretti‐Vanmarcke, Peter T. Masiakos et al. · Proceedings of the National Academy of Sciences · 2006 · 756 citations · Full text

Medicine, Oncology, Pharmacology +17

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

David B. Seifer, David T. MacLaughlin, Benjamin P. Christian et al. · Fertility and Sterility · 2002 · 495 citations

Medicine, Gynecology, Obstetrics +14

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

Mary Lee, Patricia K. Donahoe, Tomonobu Hasegawa et al. · The Journal of Clinical Endocrinology & Metabolism · 1996 · 411 citations · Full text

Medicine, Endocrinology, Oncology +17

Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes

Sibel Kantarci, Lihadh Al‐Gazali, R. Sean Hill et al. · Nature Genetics · 2007 · 319 citations · Full text

Medicine, Genetics, Molecular Genetics +6